Zobrazeno 1 - 10
of 268
pro vyhledávání: '"O, Zolk"'
Autor:
A. J. M. Meijer, F. A. Diepstraten, T. Langer, L. Broer, I. K. Domingo, E. Clemens, A. G. Uitterlinden, A. C. H. de Vries, M. van Grotel, W. P. Vermeij, R. A. Ozinga, H. Binder, J. Byrne, E. van Dulmen-den Broeder, M. L. Garrè, D. Grabow, P. Kaatsch, M. Kaiser, L. Kenborg, J. F. Winther, C. Rechnitzer, H. Hasle, T. Kepak, K. Kepakova, W. J. E. Tissing, A. L. F. van der Kooi, L. C. M. Kremer, J. Kruseova, S. M. F. Pluijm, C. E. Kuehni, H. J. H. van der Pal, R. Parfitt, C. Spix, A. Tillmanns, D. Deuster, P. Matulat, G. Calaminus, A. E. Hoetink, S. Elsner, J. Gebauer, R. Haupt, H. Lackner, C. Blattmann, S. J. C. M. M. Neggers, S. R. Rassekh, G. E. B. Wright, B. Brooks, A. P. Nagtegaal, B. I. Drögemöller, C. J. D. Ross, A. P. Bhavsar, A. G. am Zehnhoff-Dinnesen, B. C. Carleton, O. Zolk, M. M. van den Heuvel-Eibrink, the PanCareLIFE Consortium, and the CPNDS Consortium
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-8 (2021)
Abstract In children with cancer, the heterogeneity in ototoxicity occurrence after similar treatment suggests a role for genetic susceptibility. Using a genome-wide association study (GWAS) approach, we identified a genetic variant in TCERG1L (rs893
Externí odkaz:
https://doaj.org/article/1a21ee1f4f0440f184693f4b2b482abf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wim J. E. Tissing, J Kruseova, A E Hoetink, G Calaminus, R Haupt, I K Domingo, E van Dulmen-den Broeder, Amit P. Bhavsar, J Byrne, H Hasle, C Spix, S Elsner, A P Nagtegaal, L Kenborg, J Gebauer, O Zolk, S M F Pluijm, A J M Meijer, H Binder, R A Ozinga, C Rechnitzer, S J C M M Neggers, M L Garrè, P Matulat, D Deuster, T Langer, Britt I. Drögemöller, H. J. H. van der Pal, D Grabow, Leontien C. M. Kremer, Galen E.B. Wright, E Clemens, A.L.F. van der Kooi, M Kaiser, Bruce Carleton, F A Diepstraten, J F Winther, C Blattmann, L Broer, M van Grotel, R Parfitt, A G Am Zehnhoff-Dinnesen, K Kepakova, H Lackner, M M van den Heuvel-Eibrink, Shahrad Rod Rassekh, T Kepak, A. C. H. de Vries, Beth Brooks, André G. Uitterlinden, C. E. Kuehni, A Tillmanns, Wilbert P. Vermeij, Colin J. D. Ross, P Kaatsch
Publikováno v:
37. Wissenschaftliche Jahrestagung der Deutschen Gesellschaft für Phoniatrie und Pädaudiologie (DGPP); 20210917-20210918; sine loco [digital]; DOCP15 /20211028/
The PanCareLIFE Consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, no. 1, 64 . https://doi.org/10.1038/s41698-021-00178-z
Meijer, A J M, Diepstraten, F A, Langer, T, Broer, L, Domingo, I K, Clemens, E, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Vermeij, W P, Ozinga, R A, Binder, H, Byrne, J, van Dulmen-den Broeder, E, Garrè, M L, Grabow, D, Kaatsch, P, Kaiser, M, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, Kepakova, K, Tissing, W J E, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Pluijm, S M F, Kuehni, C E, van der Pal, H J H, Parfitt, R, Spix, C, Tillmanns, A, Deuster, D, Matulat, P, Calaminus, G, Hoetink, A E, Elsner, S, Gebauer, J, Haupt, R, Lackner, H, Blattmann, C, Neggers, S J C M M, Rassekh, S R, Wright, G E B, Brooks, B, Nagtegaal, A P, Drögemöller, B I, Ross, C J D, The PanCareLIFE consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, no. 1, 64 . https://doi.org/10.1038/s41698-021-00178-z
Meijer, A J M, Diepstraten, F A, Langer, T, Broer, L, Domingo, I K, Clemens, E, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Vermeij, W P, Ozinga, R A, Binder, H, Byrne, J, van Dulmen-den Broeder, E, Garrè, M L, Grabow, D, Kaatsch, P, Kaiser, M, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, Kepakova, K, Tissing, W J E, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Pluijm, S M F, Kuehni, C E, van der Pal, H J H, Parfitt, R, Spix, C, Tillmanns, A, Deuster, D, Matulat, P, Calaminus, G, Hoetink, A E, Elsner, S, Gebauer, J, Haupt, R, Lackner, H, Blattmann, C, Neggers, S J C M M, Rassekh, S R, Wright, G E B, Brooks, B, Nagtegaal, A P, Drögemöller, B I, Ross, C J D, the PanCareLIFE Consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, 64 . https://doi.org/10.1038/s41698-021-00178-z
npj Precision Oncology, 5(1):64. Springer Nature
Meijer, A J M; Diepstraten, F A; Langer, T; Broer, L; Domingo, I K; Clemens, E; Uitterlinden, A G; de Vries, A C H; van Grotel, M; Vermeij, W P; Ozinga, R A; Binder, H; Byrne, J; van Dulmen-den Broeder, E; Garrè, M L; Grabow, D; Kaatsch, P; Kaiser, M; Kenborg, L; Winther, J F; ... (2021). TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. NPJ precision oncology, 5(1), p. 64. Springer Nature 10.1038/s41698-021-00178-z
NPJ Precision Oncology
NPJ precision oncology, 5(1):64, 1-8. Nature Research
npj Precision Oncology, Vol 5, Iss 1, Pp 1-8 (2021)
The PanCareLIFE Consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, no. 1, 64 . https://doi.org/10.1038/s41698-021-00178-z
Meijer, A J M, Diepstraten, F A, Langer, T, Broer, L, Domingo, I K, Clemens, E, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Vermeij, W P, Ozinga, R A, Binder, H, Byrne, J, van Dulmen-den Broeder, E, Garrè, M L, Grabow, D, Kaatsch, P, Kaiser, M, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, Kepakova, K, Tissing, W J E, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Pluijm, S M F, Kuehni, C E, van der Pal, H J H, Parfitt, R, Spix, C, Tillmanns, A, Deuster, D, Matulat, P, Calaminus, G, Hoetink, A E, Elsner, S, Gebauer, J, Haupt, R, Lackner, H, Blattmann, C, Neggers, S J C M M, Rassekh, S R, Wright, G E B, Brooks, B, Nagtegaal, A P, Drögemöller, B I, Ross, C J D, The PanCareLIFE consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, no. 1, 64 . https://doi.org/10.1038/s41698-021-00178-z
Meijer, A J M, Diepstraten, F A, Langer, T, Broer, L, Domingo, I K, Clemens, E, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Vermeij, W P, Ozinga, R A, Binder, H, Byrne, J, van Dulmen-den Broeder, E, Garrè, M L, Grabow, D, Kaatsch, P, Kaiser, M, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, Kepakova, K, Tissing, W J E, van der Kooi, A L F, Kremer, L C M, Kruseova, J, Pluijm, S M F, Kuehni, C E, van der Pal, H J H, Parfitt, R, Spix, C, Tillmanns, A, Deuster, D, Matulat, P, Calaminus, G, Hoetink, A E, Elsner, S, Gebauer, J, Haupt, R, Lackner, H, Blattmann, C, Neggers, S J C M M, Rassekh, S R, Wright, G E B, Brooks, B, Nagtegaal, A P, Drögemöller, B I, Ross, C J D, the PanCareLIFE Consortium & and the CPNDS Consortium 2021, ' TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study ', npj Precision Oncology, vol. 5, 64 . https://doi.org/10.1038/s41698-021-00178-z
npj Precision Oncology, 5(1):64. Springer Nature
Meijer, A J M; Diepstraten, F A; Langer, T; Broer, L; Domingo, I K; Clemens, E; Uitterlinden, A G; de Vries, A C H; van Grotel, M; Vermeij, W P; Ozinga, R A; Binder, H; Byrne, J; van Dulmen-den Broeder, E; Garrè, M L; Grabow, D; Kaatsch, P; Kaiser, M; Kenborg, L; Winther, J F; ... (2021). TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. NPJ precision oncology, 5(1), p. 64. Springer Nature 10.1038/s41698-021-00178-z
NPJ Precision Oncology
NPJ precision oncology, 5(1):64, 1-8. Nature Research
npj Precision Oncology, Vol 5, Iss 1, Pp 1-8 (2021)
Background: Ototoxicity (hearing loss, tinnitus and/or vertigo) is a serious adverse event of cisplatin treatment in children with cancer. The heterogeneity in ototoxicity occurrence after similar treatment suggests a role for genetic susceptibility.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87b1abb74a67b5c6ca531ead07151865
http://www.egms.de/en/meetings/dgpp2021/21dgpp30.shtml
http://www.egms.de/en/meetings/dgpp2021/21dgpp30.shtml
Autor:
van Leeuwen Fe, van Dijk M, Dalit Modan-Moses, Dorine Bresters, Claudia Spix, C.B. Lambalk, Jacqueline J. Loonen, Eva Clemens, A. Overbeek, Wassim Chemaitilly, van den Berg Mh, Gertjan L. Kaspers, Beerendonk Ccm, L. L. Robison, Sophie D. Fosså, van der Heiden-van der Loo M, Desiree Grabow, Peter Kaatsch, A.G. Uitterlinden, Melissa M. Hudson, van den Heuvel-Eibrink M, Russell J. Brooke, L. C. M. Kremer, van der Pal Hj, W.J.E. (Wim) Tissing, Falck Winther J, van der Kooi Alf, J. Kruseova, Uta Dirksen, Laven Jse, Claire Berger, Tomáš Kepák, Ronckers Cr, James M. Byrne, Pluijm Smf, Melanie Kaiser, de Vries Ach, Mvan Dulmen-den Broeder E, Linda Broer, Yutaka Yasui, Jesse H. Krijthe, Birgitta Versluys, O. Zolk, Riccardo Haupt
Publikováno v:
Human Reproduction, 36(4), 1120-1133. Oxford University Press
van der Kooi, A L L F, van Dijk, M, Broer, L, van den Berg, M H, Laven, J S E, van Leeuwen, F E, Lambalk, C B, Overbeek, A, Loonen, J J, van der Pal, H J, Tissing, W J, Versluys, B, Bresters, D, Beerendonk, C C M, Ronckers, C R, van der Heiden-van der Loo, M, Kaspers, G L, de Vries, A C H, Robison, L L, Hudson, M M, Chemaitilly, W, Byrne, J, Berger, C, Clemens, E, Dirksen, U, Falck Winther, J, Fosså, S D, Grabow, D, Haupt, R, Kaiser, M, Kepak, T, Kruseova, J, Modan-Moses, D, Pluijm, S M F, Spix, C, Zolk, O, Kaatsch, P, Krijthe, J H, Kremer, L C, Yasui, Y, Brooke, R J, Uitterlinden, A G, van den Heuvel-Eibrink, M M & van Dulmen-den Broeder, E 2021, ' Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function ', Human Reproduction, vol. 36, no. 4, pp. 1120-1133 . https://doi.org/10.1093/humrep/deaa342
Human Reproduction (Oxford, England)
Human Reproduction, 36, 4, pp. 1120-1133
Human Reproduction, 36, 1120-1133
van der Kooi, A-L L F, van Dijk, M, Broer, L, van den Berg, M H, Laven, J S E, van Leeuwen, F E, Lambalk, C B, Overbeek, A, Loonen, J J, van der Pal, H J, Tissing, W J, Versluys, B, Bresters, D, Beerendonk, C C M, Ronckers, C C R, van der Heiden-van der Loo, M, Kaspers, G L, de Vries, A C H, Robison, L L, Hudson, M M, Chemaitilly, W, Byrne, J, Berger, C, Clemens, E, Dirksen, U, Falck Winther, J, Fosså, S D, Grabow, D, Haupt, R, Kaiser, M, Kepak, T, Kruseova, J, Modan-Moses, D, Pluijm, S M F, Spix, C, Zolk, O, Kaatsch, P, Krijthe, J H, Kremer, L C, Yasui, Y, Brooke, R J, Uitterlinden, A G, van den Heuvel-Eibrink, M M & van Dulmen-den Broeder, E 2021, ' Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function ', Human Reproduction, vol. 36, no. 4, pp. 1120-1133 . https://doi.org/10.1093/humrep/deaa342
van der Kooi, A L L F, van Dijk, M, Broer, L, van den Berg, M H, Laven, J S E, van Leeuwen, F E, Lambalk, C B, Overbeek, A, Loonen, J J, van der Pal, H J, Tissing, W J, Versluys, B, Bresters, D, Beerendonk, C C M, Ronckers, C R, van der Heiden-van der Loo, M, Kaspers, G L, de Vries, A C H, Robison, L L, Hudson, M M, Chemaitilly, W, Byrne, J, Berger, C, Clemens, E, Dirksen, U, Falck Winther, J, Fosså, S D, Grabow, D, Haupt, R, Kaiser, M, Kepak, T, Kruseova, J, Modan-Moses, D, Pluijm, S M F, Spix, C, Zolk, O, Kaatsch, P, Krijthe, J H, Kremer, L C, Yasui, Y, Brooke, R J, Uitterlinden, A G, van den Heuvel-Eibrink, M M & van Dulmen-den Broeder, E 2021, ' Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function ', Human Reproduction, vol. 36, no. 4, pp. 1120-1133 . https://doi.org/10.1093/humrep/deaa342
Human Reproduction (Oxford, England)
Human Reproduction, 36, 4, pp. 1120-1133
Human Reproduction, 36, 1120-1133
van der Kooi, A-L L F, van Dijk, M, Broer, L, van den Berg, M H, Laven, J S E, van Leeuwen, F E, Lambalk, C B, Overbeek, A, Loonen, J J, van der Pal, H J, Tissing, W J, Versluys, B, Bresters, D, Beerendonk, C C M, Ronckers, C C R, van der Heiden-van der Loo, M, Kaspers, G L, de Vries, A C H, Robison, L L, Hudson, M M, Chemaitilly, W, Byrne, J, Berger, C, Clemens, E, Dirksen, U, Falck Winther, J, Fosså, S D, Grabow, D, Haupt, R, Kaiser, M, Kepak, T, Kruseova, J, Modan-Moses, D, Pluijm, S M F, Spix, C, Zolk, O, Kaatsch, P, Krijthe, J H, Kremer, L C, Yasui, Y, Brooke, R J, Uitterlinden, A G, van den Heuvel-Eibrink, M M & van Dulmen-den Broeder, E 2021, ' Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function ', Human Reproduction, vol. 36, no. 4, pp. 1120-1133 . https://doi.org/10.1093/humrep/deaa342
STUDY QUESTION Do genetic variations in the DNA damage response pathway modify the adverse effect of alkylating agents on ovarian function in female childhood cancer survivors (CCS)? SUMMARY ANSWER Female CCS carrying a common BR serine/threonine kin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ae7c525b5d2c7161af711da3873f478
https://research.rug.nl/en/publications/063b1e16-52a7-45b0-b625-23f28047a5d1
https://research.rug.nl/en/publications/063b1e16-52a7-45b0-b625-23f28047a5d1
Autor:
A Meijer, Antoinette am Zehnhoff-Dinnesen, Claudia Lanvers-Kaminsky, O. Zolk, Marry M. van den Heuvel-Eibrink
Publikováno v:
Late Treatment Effects and Cancer Survivor Care in the Young ISBN: 9783030491383
Polymorphisms in genes can affect the efficacy of drugs in individual patients as well as their risk for adverse drug reactions. This particularly applies for life-saving drugs with narrow therapeutic ranges, which can induce irreversible disabling s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4447650280cd652d82f5a9283d178586
https://doi.org/10.1007/978-3-030-49140-6_37
https://doi.org/10.1007/978-3-030-49140-6_37
Autor:
Julianne Byrne, Desiree Grabow, Helen Campbell, Kylie O'Brien, Stefan Bielack, Antoinette am Zehnhoff-Dinnesen, Gabriele Calaminus, Leontien Kremer, Thorsten Langer, Marry M. van den Heuvel-Eibrink, Eline van Dulmen-den Broeder, Katja Baust, Andrea Bautz, Jörn D. Beck, Claire Berger, Harald Binder, Anja Borgmann-Staudt, Linda Broer, Holger Cario, Leonie Casagranda, Eva Clemens, Dirk Deuster, Andrica de Vries, Uta Dirksen, Jeanette Falck Winther, Sophie Fosså, Anna Font-Gonzalez, Victoria Grandage, Riccardo Haupt, Stefanie Hecker-Nolting, Lars Hjorth, Melanie Kaiser, Line Kenborg, Tomas Kepak, Kateřina Kepáková, Lisbeth E. Knudsen, Maryna Krawczuk-Rybak, Jarmila Kruseova, Claudia E. Kuehni, Marina Kunstreich, Rahel Kuonen, Herwig Lackner, Alison Leiper, Erik A.H. Loeffen, Ales Luks, Dalit Modan-Moses, Renee Mulder, Ross Parfitt, Norbert W. Paul, Andreas Ranft, Ellen Ruud, Ralph Schilling, Claudia Spix, Joanna Stefanowicz, Gabriele Strauβ, Andre G. Uitterlinden, Marleen van den Berg, Anne-Lotte van der Kooi, Marloes van Dijk, Flora van Leeuwen, Oliver Zolk, Daniela Zöller, Peter Kaatsch, P. Kaatsch, D. Grabow, J. Byrne, H. Campbell, C. Clissmann, K. O'Brien, L.C.M. Kremer, T. Langer, E. van Dulmen-den Broeder, Dr. MH. van den Berg, M.M. van den Heuvel-Eibrink, A. Borgmann-Staudt, A. am Zehnhoff-Dinnesen, C.E. Kuehni, R. Haupt, T. Kepak, C. Berger, J.F. Winther, J. Kruseova, G. Calaminus, K. Baust, U. Dirksen, F. van Leeuwen, R. Schilling, G. Strauss, A. Ranft, M.-L. Garré, S. Fosså, A. Leiper, H. Lackner, A. Panasiuk, Dr. M. Krawczuk-Rybak, M. Kunstreich, H. Cario, O. Zolk, S. Bielack, J. Stefanowicz, V. Grandage, D. Modan
Publikováno v:
European journal of cancer (Oxford, England, 103, 227-237. Elsevier Limited
European Journal of Cancer, 103, 227-237. Elsevier Ltd.
European Journal of Cancer, 103, 227-237. Pergamon
Byrne, J, Grabow, D, Campbell, H, O'Brien, K, Bielack, S, am Zehnhoff-Dinnesen, A, Calaminus, G, Kremer, L, Langer, T, van den Heuvel-Eibrink, M M, van Dulmen-den Broeder, E, Baust, K, Bautz, A, Beck, J R D, Berger, C, Binder, H, Borgmann-Staudt, A, Broer, L, Cario, H, Casagranda, L, Clemens, E, Deuster, D, de Vries, A, Dirksen, U, Falck Winther, J, Fosså, S, Font-Gonzalez, A, Grandage, V, Haupt, R, Hecker-Nolting, S, Hjorth, L, Kaiser, M, Kenborg, L, Kepak, T, Kepáková, K, Knudsen, L E, Krawczuk-Rybak, M, Kruseova, J, Kuehni, C E, Kunstreich, M, Kuonen, R, Lackner, H, Leiper, A, Loeffen, E A H, Luks, A, Modan-Moses, D, Mulder, R, Parfitt, R, Paul, N W, Ranft, A, Ruud, E, Schilling, R, Spix, C, Stefanowicz, J, Strauβ, G, Uitterlinden, A G, van den Berg, M, van der Kooi, A-L, van Dijk, M, van Leeuwen, F, Zolk, O, Zöller, D, Kaatsch, P, Kaatsch, P, Grabow, D, Byrne, J, Campbell, H, Clissmann, C, O'Brien, K, Kremer, L C M, Langer, T, van Dulmen-den Broeder, E, van den Berg, D M H, van den Heuvel-Eibrink, M M, Borgmann-Staudt, A, am Zehnhoff-Dinnesen, A, Kuehni, C E, Haupt, R, Kepak, T, Berger, C, Winther, J F, Kruseova, J, Calaminus, G, Baust, K, Dirksen, U, van Leeuwen, F, Schilling, R, Strauss, G, Ranft, A, Garré, M L, Berger, C, Fosså, S, Leiper, A, Lackner, H, Panasiuk, A, Krawczuk-Rybak, D M, Kunstreich, M, Cario, H, Zolk, O, Bielack, S, Stefanowicz, J, Grandage, V, Modan, D, Paul, N W & Knudsen, L E 2018, ' PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents ', European Journal of Cancer, vol. 103, pp. 227-237 . https://doi.org/10.1016/j.ejca.2018.08.007
Byrne, J, Grabow, D, Campbell, H, O'Brien, K, Bielack, S, Am Zehnhoff-Dinnesen, A, Calaminus, G, Kremer, L, Langer, T, van den Heuvel-Eibrink, M M, van Dulmen-den Broeder, E, Baust, K, Bautz, A, Beck, J D, Berger, C, Binder, H, Borgmann-Staudt, A, Broer, L, Cario, H, Casagranda, L, Clemens, E, Deuster, D, de Vries, A, Dirksen, U, Falck Winther, J, Fosså, S, Font-Gonzalez, A, Grandage, V, Haupt, R, Hecker-Nolting, S, Hjorth, L, Kaiser, M, Kenborg, L, Kepak, T, Kepáková, K, Knudsen, L E, Krawczuk-Rybak, M, Kruseova, J, Kuehni, C E, Kunstreich, M, Kuonen, R, Lackner, H, Leiper, A, Loeffen, E A H, Luks, A, Modan-Moses, D, Mulder, R & PanCareLIFE Consortium 2018, ' PanCareLIFE : The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents ', European journal of cancer (Oxford, England : 1990), vol. 103, pp. 227-237 . https://doi.org/10.1016/j.ejca.2018.08.007
European Journal of Cancer, 103, 227-237. ELSEVIER SCI LTD
European Journal of Cancer, 103, 227-237. Elsevier Ltd.
European Journal of Cancer, 103, 227-237. Pergamon
Byrne, J, Grabow, D, Campbell, H, O'Brien, K, Bielack, S, am Zehnhoff-Dinnesen, A, Calaminus, G, Kremer, L, Langer, T, van den Heuvel-Eibrink, M M, van Dulmen-den Broeder, E, Baust, K, Bautz, A, Beck, J R D, Berger, C, Binder, H, Borgmann-Staudt, A, Broer, L, Cario, H, Casagranda, L, Clemens, E, Deuster, D, de Vries, A, Dirksen, U, Falck Winther, J, Fosså, S, Font-Gonzalez, A, Grandage, V, Haupt, R, Hecker-Nolting, S, Hjorth, L, Kaiser, M, Kenborg, L, Kepak, T, Kepáková, K, Knudsen, L E, Krawczuk-Rybak, M, Kruseova, J, Kuehni, C E, Kunstreich, M, Kuonen, R, Lackner, H, Leiper, A, Loeffen, E A H, Luks, A, Modan-Moses, D, Mulder, R, Parfitt, R, Paul, N W, Ranft, A, Ruud, E, Schilling, R, Spix, C, Stefanowicz, J, Strauβ, G, Uitterlinden, A G, van den Berg, M, van der Kooi, A-L, van Dijk, M, van Leeuwen, F, Zolk, O, Zöller, D, Kaatsch, P, Kaatsch, P, Grabow, D, Byrne, J, Campbell, H, Clissmann, C, O'Brien, K, Kremer, L C M, Langer, T, van Dulmen-den Broeder, E, van den Berg, D M H, van den Heuvel-Eibrink, M M, Borgmann-Staudt, A, am Zehnhoff-Dinnesen, A, Kuehni, C E, Haupt, R, Kepak, T, Berger, C, Winther, J F, Kruseova, J, Calaminus, G, Baust, K, Dirksen, U, van Leeuwen, F, Schilling, R, Strauss, G, Ranft, A, Garré, M L, Berger, C, Fosså, S, Leiper, A, Lackner, H, Panasiuk, A, Krawczuk-Rybak, D M, Kunstreich, M, Cario, H, Zolk, O, Bielack, S, Stefanowicz, J, Grandage, V, Modan, D, Paul, N W & Knudsen, L E 2018, ' PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents ', European Journal of Cancer, vol. 103, pp. 227-237 . https://doi.org/10.1016/j.ejca.2018.08.007
Byrne, J, Grabow, D, Campbell, H, O'Brien, K, Bielack, S, Am Zehnhoff-Dinnesen, A, Calaminus, G, Kremer, L, Langer, T, van den Heuvel-Eibrink, M M, van Dulmen-den Broeder, E, Baust, K, Bautz, A, Beck, J D, Berger, C, Binder, H, Borgmann-Staudt, A, Broer, L, Cario, H, Casagranda, L, Clemens, E, Deuster, D, de Vries, A, Dirksen, U, Falck Winther, J, Fosså, S, Font-Gonzalez, A, Grandage, V, Haupt, R, Hecker-Nolting, S, Hjorth, L, Kaiser, M, Kenborg, L, Kepak, T, Kepáková, K, Knudsen, L E, Krawczuk-Rybak, M, Kruseova, J, Kuehni, C E, Kunstreich, M, Kuonen, R, Lackner, H, Leiper, A, Loeffen, E A H, Luks, A, Modan-Moses, D, Mulder, R & PanCareLIFE Consortium 2018, ' PanCareLIFE : The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents ', European journal of cancer (Oxford, England : 1990), vol. 103, pp. 227-237 . https://doi.org/10.1016/j.ejca.2018.08.007
European Journal of Cancer, 103, 227-237. ELSEVIER SCI LTD
Aims: Survival after cancer diagnosed during childhood or adolescence continues to improve with new treatments and supportive therapies. Optimal long-term care requires that risks to vulnerable organs are clearly defined and translated into guideline
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bf2bb2aae40d3f29acde6b390e2a374
https://research.rug.nl/en/publications/2fc01e58-3b38-4661-8cda-4684196938e5
https://research.rug.nl/en/publications/2fc01e58-3b38-4661-8cda-4684196938e5